Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; 1:200; loading ...; fig 2f
| Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
|
| Marsman C, Verhoeven D, Koers J, Rispens T, ten Brinke A, Van Ham S, et al. Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells. Front Immunol. 2022;13:815449 pubmed publisher
|
| Ercanoglu M, Gieselmann L, D xe4 hling S, Poopalasingam N, Detmer S, Koch M, et al. No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. iScience. 2022;25:103951 pubmed publisher
|
| Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, et al. A humanized mouse model of chronic COVID-19. Nat Biotechnol. 2021;: pubmed publisher
|
| Feldman J, Bals J, Altomare C, St Denis K, Lam E, Hauser B, et al. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Sci Immunol. 2021;6:eabl5842 pubmed publisher
|
| Deakin C, Cornish G, Ng K, Faulkner N, Bolland W, Hope J, et al. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med. 2021;2:1093-1109.e6 pubmed publisher
|
| Faulkner N, Ng K, Wu M, Harvey R, Margaritis M, Paraskevopoulou S, et al. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. elife. 2021;10: pubmed publisher
|
| Brouwer P, Brinkkemper M, Maisonnasse P, Dereuddre Bosquet N, Grobben M, Claireaux M, et al. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021;184:1188-1200.e19 pubmed publisher
|
| Jongsma M, de Waard A, Raaben M, Zhang T, Cabukusta B, Platzer R, et al. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses. Immunity. 2021;54:132-150.e9 pubmed publisher
|
| Pellett Madan R, Penkert R, Surman S, Jones B, Houston J, Lamour J, et al. Persistent hypogammaglobulinemia in pediatric solid organ transplant recipients. Clin Transplant. 2020;34:e14021 pubmed publisher
|
| Gang E, Kim H, Hsieh Y, Ruan Y, Ogana H, Lee S, et al. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020;136:210-223 pubmed publisher
|
| Shehata L, Maurer D, Wec A, Lilov A, Champney E, Sun T, et al. Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability. Cell Rep. 2019;28:3300-3308.e4 pubmed publisher
|
| Watanabe A, McCarthy K, Kuraoka M, Schmidt A, Adachi Y, Onodera T, et al. Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism. Cell. 2019;177:1124-1135.e16 pubmed publisher
|
| Mclaurin J, Weiner O. Multiple sources of signal amplification within the B-cell Ras/MAPK pathway. Mol Biol Cell. 2019;30:1610-1620 pubmed publisher
|
| Villar R, Patel J, Weaver G, Kanekiyo M, Wheatley A, Yassine H, et al. Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation. Sci Rep. 2016;6:36298 pubmed publisher
|
| Perez Shibayama C, Gil Cruz C, Pastelin Palacios R, Cervantes Barragan L, Hisaki E, Chai Q, et al. IFN-?-producing CD4+ T cells promote generation of protective germinal center-derived IgM+ B cell memory against Salmonella Typhi. J Immunol. 2014;192:5192-200 pubmed publisher
|